Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China · Delayed Price · Currency is CNY 42.19
+0.27 (0.64%)
Apr 8, 2026, 3:00 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 13.6 billion as of April 8, 2026. Its market cap has increased by 18.38% in one year.
Market Cap
13.60B
Enterprise Value
11.33B
Revenue
2.98B
Ranking
n/a
PE Ratio
14.50
Stock Price
42.19
Market Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 13.60B, an increase of 839.10%. That is a compound annual growth rate of 8.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 13.51B | -1.48% |
| Dec 31, 2025 | 13.71B | 15.19% |
| Dec 31, 2024 | 11.91B | -1.59% |
| Dec 29, 2023 | 12.10B | 35.86% |
| Dec 30, 2022 | 8.91B | -31.40% |
| Dec 31, 2021 | 12.98B | -22.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group | 15.13B |
| Zhejiang Jiuzhou Pharmaceutical | 15.03B |
| Zhejiang Medicine | 14.94B |
| Beijing Aosaikang Pharmaceutical | 14.82B |
| Shanghai Haoyuan Chemexpress | 14.79B |
| Shanghai Shyndec Pharmaceutical | 14.14B |
| Guobang Pharma | 14.07B |
| Zhejiang Jingxin Pharmaceutical | 13.36B |